Austin, TX – According to filings with the U.S. Securities and Exchange Commission, Aspira Women’s Health is raising $11,025,000.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Robert Beechey played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Aspira Women’s Health

Aspira Women’s Health Inc. (formerly known as Vermillion, Inc. Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women.

To learn more about Aspira Women’s Health, visit http://aspirawh.com/

Contact:
Robert Beechey, Chief Financial Officer
844-277-4721
https://www.linkedin.com/in/bob-beechey-b207152/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved